1.Discrepant results by High Protein Anti-D and Low Protein Anti-D in a D Negative Newborn.
Jin Woo YOO ; Suk Woo CHOI ; Seongsoo JANG ; Nak Eun CHUNG
Korean Journal of Clinical Pathology 2001;21(3):221-224
High-protein anti-D reagents prepared from pools of human serum have been used for routine RhD typing but, low-protein, saline reactive anti-D reagents formulated predominantly with monoclonal antibodies are in current use. Because some of the high-protein reagents contain macromolecular additives that may cause red cells coated with immunoglobulin to aggregate spontaneously, antisera with these additives may produce a false-positive reaction. A four-day old male was admitted due to severe jaundice. Initially, the RhD type of the newborn using a high-protein reagent was D-positive and then, using two low-protein reagents, it was D-negative. The blood type of the mother was B, CDe, and that of the newborn was B, CcdEe. The direct antiglobulin test on the newborn's RBC was positive. Anti-E and anti-c were identified in the mother's serum and anti-E only was identified in the newborn's serum. The newborn was treated with phototherapy for 10 days and discharged as recovered. We present a case of hemolytic disease of the D negative newborn, which showed a discrepancy between high protein anti-D and low protein anti-D. With a review of literature, the newborn was possibly misinterpreted as D positive.
Antibodies, Monoclonal
;
Coombs Test
;
Humans
;
Immune Sera
;
Immunoglobulins
;
Indicators and Reagents
;
Infant, Newborn*
;
Jaundice
;
Male
;
Mothers
;
Phototherapy
2.Evaluation of the Clinical Usefulness for Pancreatic Amylase in Acute Pancreatitis.
Sukwoo CHOI ; Chunwha IHM ; Seongsoo JANG
The Korean Journal of Laboratory Medicine 2003;23(2):98-103
BACKGROUND: Recently, a new EIA method for pancreatic amylase was introduced that was assayed by inhibition of the salivary amylase using the synergistic action of two monoclonal antibodies. We evaluated the clinical usefulness of the pancreatic amylase by using the sensitivity, the specificity and diagnostic accuracy of the receiver-operator characteristics (ROC) curve. METHODS: We divided into 3 groups: acute pancreatitis (n=26) diagnosed by ultrasonography and computed tomography, control patients (n=105), and healthy controls (n=95). Serum total amylase, pancreatic amylase, and lipase were assayed by the Hitachi 7170. The upper limit of the reference range of the total amylase, pancreatic amylase, and lipase was respectively 216 U/L, 115 U/L and 200 U/L in this hospital. RESULTS: The sensitivity of total amylase, pancreatic amylase, and lipase for the diagnosis of acute pancreatitis was 73.1%, 88.5%, and 92.3%, respectively. The specificity of total amylase, pancreatic amylase, and lipase was 70.5%, 81.9%, and 82.9%, respectively. The diagnostic accuracy, determined as the area under the curve, was 0.795 for total amylase, 0.868 for pancreatic amylase, and 0.886 for lipase. There was a significant difference between the total amylase and pancreatic amylase (P=0.045), but not a significant difference between the pancreatic amylase and lipase (P=0.613) by ROC curve. CONCLUSIONS: Pancreatic amylase had a higher sensitivity, specificity, and diagnostic accuracy than the total amylase, and showed a similar diagnostic performance as lipase. Therefore, we concluded that the pancreatic amylase was a better diagnostic tool than the total amylase in the diagnosis of acute pancreatitis.
Amylases*
;
Antibodies, Monoclonal
;
Diagnosis
;
Humans
;
Lipase
;
Pancreatitis*
;
Reference Values
;
ROC Curve
;
Sensitivity and Specificity
;
Ultrasonography
3.Differentiation of Varieties and Susceptibility Testing for Two Strains of Cryptococcus neoformans.
Jong Woo KIM ; Seongsoo JANG ; Jung Oak KANG ; Tae Yeal CHOI
Korean Journal of Clinical Pathology 1998;18(4):550-553
Typing of cryptococcal varieties and antifungal susceptibility testing were performed on two strains which were isolated from a nonimmunosuppressed host with cryptococcal meningitis and another from a patient with systemic cryptococcosis with underlying liver cirrhosis. Both varieties of clinical isolates were identified by the use of the glycin-cycloheximide-bromothymol blue agar medium as Cryptococcus neoformans variety neoformans. For the two isolates of Cryptococcus neoformans, the minimal inhibitory concentrations (MIC) of amphotericin B were 0.25 g/mL and the MICs of fluconazole were 8 g/mL.
Agar
;
Amphotericin B
;
Cryptococcosis
;
Cryptococcus neoformans*
;
Cryptococcus*
;
Fluconazole
;
Humans
;
Liver Cirrhosis
;
Meningitis, Cryptococcal
4.A Case of Histiocytic Sarcoma Diagnosed by Bone Marrow Biopsy in a Patient Suffering from Fever for 8 Months.
Yun Ha JANG ; Chan Jeong PARK ; Joo Ryong HUH ; Seongsoo JANG ; Hyun Sook CHI
The Korean Journal of Laboratory Medicine 2009;29(4):282-285
Histiocytic sarcoma is a malignant proliferation of cells showing morphologic and immunophenotypic features similar to those of mature tissue histiocytes and is known for its rapid progression and poor prognosis. We describe a case of histiocytic sarcoma diagnosed by bone marrow biopsy. A 64-yr-old male was admitted for fever and weight loss that persisted for 8 months. The patient died undiagnosed on the 7th hospitalization day. A bone marrow biopsy performed just before the patient's death revealed diffuse proliferation of large pleomorphic neoplastic cells with large, round to oval nuclei, vesicular chromatin, and abundant foamy cytoplasm. These cells were positive for histiocytic markers, CD68, lysozyme, CD21, and S-100 protein, but negative for B-cell, T/NK-cell, and epithelial cell markers, thus confirming the presence of histiocytic sarcoma.
Antigens, CD/metabolism
;
Antigens, CD31/metabolism
;
Antigens, Differentiation, Myelomonocytic/metabolism
;
Bone Marrow/*pathology
;
Fever/diagnosis
;
Histiocytic Sarcoma/*diagnosis/pathology/radiography
;
Humans
;
Male
;
Middle Aged
;
Muramidase/metabolism
;
S100 Proteins/metabolism
;
Tomography, X-Ray Computed
5.Performance Evaluation of Five Different Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Predicting Mortality in Patients with Complicated Sepsis.
Sang Ook HA ; Sang Hyuk PARK ; Sang Bum HONG ; Seongsoo JANG
Journal of Korean Medical Science 2016;31(11):1838-1845
Disseminated intravascular coagulation (DIC) is a major complication in sepsis patients. We compared the performance of five DIC diagnostic criteria, focusing on the prediction of mortality. One hundred patients with severe sepsis or septic shock admitted to intensive care unit (ICU) were enrolled. Routine DIC laboratory tests were performed over the first 4 days after admission. The overall ICU and 28-day mortality in DIC patients diagnosed from five criteria (International Society on Thrombosis and Haemostasis [ISTH], the Japanese Association for Acute Medicine [JAAM], the revised JAAM [R-JAAM], the Japanese Ministry of Health and Welfare [JMHW] and the Korean Society on Thrombosis and Hemostasis [KSTH]) were compared. Both KSTH and JMHW criteria showed superior performance than ISTH, JAAM and R-JAAM criteria in the prediction of overall ICU mortality in DIC patients (odds ratio 3.828 and 5.181, P = 0.018 and 0.006, 95% confidence interval 1.256–11.667 and 1.622–16.554, respectively) when applied at day 1 after admission, and survival analysis demonstrated significant prognostic impact of KSTH and JMHW criteria on the prediction of 28-day mortality (P = 0.007 and 0.049, respectively) when applied at day 1 after admission. In conclusion, both KSTH and JMHW criteria would be more useful than other three criteria in predicting prognosis in DIC patients with severe sepsis or septic shock.
Asian Continental Ancestry Group
;
Dacarbazine
;
Diagnosis
;
Disseminated Intravascular Coagulation*
;
Hemostasis
;
Humans
;
Intensive Care Units
;
Mortality*
;
Prognosis
;
Sepsis*
;
Shock, Septic
;
Thrombosis
6.The allele burden of JAK2 V617F can aid in differential diagnosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.
Sang Hyuk PARK ; Hyun Sook CHI ; Young Uk CHO ; Seongsoo JANG ; Chan Jeoung PARK
Blood Research 2013;48(2):128-132
BACKGROUND: We aimed to evaluate the feasibility of using the allele burden of Janus kinase 2 (JAK2) V617F as a criterion for discriminating 3 subtypes of Philadelphia chromosome-negative myeloproliferative neoplasm (Ph-MPN): polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). METHODS: We collected 70 peripheral blood (PB) and 81 bone marrow (BM) samples from patients diagnosed with Ph-MPN. Real-time quantitative PCR (RQ-PCR) and Amplification Refractory Mutation System (ARMS) assays were performed for each sample. We compared the allele burden of JAK2 V617F for each subtype of Ph-MPN and determined the concordance rates of the results between the 2 tests. RESULTS: The JAK2 V617F allele burden differed significantly among the 3 disease categories in both PB (P=0.045) and BM (P=0.011) samples. Subsequent subgroup analysis revealed that the median allele burden of JAK2 V617F for ET (21.71% for PB and 24.95% for BM) was significantly lower than that for PV (56.88% for PB, P=0.047; 72.66% for BM, P=0.003) and PMF (56.16% for PB, P=0.050; 59.04% for BM, P=0.049). Concordance rate between the RQ-PCR and ARMS data was 90.7%. Of the 14 discrepant cases, 12 were RQ-PCR(+)/ARMS(-) and 2 were RQ-PCR(-)/ARMS(+). CONCLUSION: The allele burden of JAK2 V617F was significantly lower for ET than that for PV or PMF in both PB and BM samples. The JAK2 V617F allele burden is a diagnostic tool for differentiating PV or PMF from ET.
Alleles
;
Arm
;
Bone Marrow
;
Diagnosis, Differential
;
Discrimination (Psychology)
;
Humans
;
Janus Kinase 2
;
Myeloproliferative Disorders
;
Philadelphia
;
Polycythemia Vera
;
Polymerase Chain Reaction
;
Primary Myelofibrosis
;
Real-Time Polymerase Chain Reaction
;
Thrombocythemia, Essential
7.Straightforward Identification of Masked Polycythemia Vera Based on Proposed Revision of World Health Organization Diagnostic Criteria for BCR-ABL1-Negative Myeloproliferative Neoplasms.
Daehyun CHU ; Young Uk CHO ; Seongsoo JANG ; Eul Ju SEO ; Chan Jeoung PARK
Annals of Laboratory Medicine 2015;35(6):651-653
No abstract available.
Adult
;
Biomarkers, Tumor/genetics
;
Bone Marrow/pathology
;
Calreticulin/genetics
;
Erythropoietin/blood
;
Female
;
Fusion Proteins, bcr-abl/*genetics
;
Hematocrit
;
Hemoglobins/analysis
;
Humans
;
Janus Kinase 2/genetics
;
Male
;
Middle Aged
;
Mutation
;
Myeloproliferative Disorders/*diagnosis/genetics
;
Polycythemia Vera/*diagnosis/genetics
;
Receptors, Thrombopoietin/genetics
;
Thrombocythemia, Essential/diagnosis
;
World Health Organization
8.Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia.
Sang Hyuk PARK ; Hyun Sook CHI ; Young Uk CHO ; Seongsoo JANG ; Chan Jeoung PARK
Blood Research 2013;48(3):185-192
BACKGROUND: Therapy-related AML (t-AML) occurs as a late complication of chemotherapy administered to treat a prior disorder. Prognostic factors affecting the clinical outcome in t-AML have not yet been clearly defined; therefore, we evaluated these factors in this study. METHODS: Forty-eight patients diagnosed with t-AML within the past 10 years were enrolled, and their chemotherapy regimens categorized into 4 groups: alkylating agents (AK) only, topoisomerase II inhibitors (TI) and AK, TI only, and others. The prognostic factors affecting clinical outcome were evaluated. RESULTS: Five (10.4%), 21 (43.8%), 9 (18.8%), and 13 (27.0%) patients were treated with AK only, AK and TI, TI only, and others, respectively. Patients with an AML M3 phenotype showed significantly longer overall survival (OS; 55.1 vs. 14.3 months, P=0.040) and disease-free survival (DFS; 61.2 vs. 17.5 months, P=0.049) than other phenotypes. In contrast, patients with a complex karyotype showed significantly shorter OS (7.9 vs. 31.3 months, P=0.008) and DFS (9.5 vs. 38.6 months, P=0.046); additionally, patients with chromosome 5 or 7 abnormalities showed significantly shorter OS (9.1 vs. 30.7 months, P=0.011) than other phenotypes. Only the presence of a complex karyotype or AML M3 phenotype retained prognostic impact in a multivariate analysis. CONCLUSION: Only the AML M3 phenotype was identified as having a good prognosis, and this might suggest that it exhibits unique clinical features in t-AML patients. Moreover, our findings indicated that karyotype was the strongest prognostic indicator and predicted a poor prognosis for t-AML patients with a complex karyotype.
Alkylating Agents
;
Chromosomes, Human, Pair 5
;
Disease-Free Survival
;
Humans
;
Karyotype
;
Leukemia, Myeloid, Acute
;
Phenotype
;
Prognosis
;
Topoisomerase II Inhibitors
9.Rapid Detection of Prognostically Significant Fusion Transcripts in Acute Leukemia Using Simplified Multiplex Reverse Transcription Polymerase Chain Reaction.
Young Uk CHO ; Hyun Sook CHI ; Chan Jeoung PARK ; Seongsoo JANG ; Eul Ju SEO
Journal of Korean Medical Science 2012;27(10):1155-1161
Multiplex reverse transcription polymerase chain reaction (mRT-PCR) has recently emerged as an alternative to cytogenetics. We designed and used simplified mRT-PCR system as a molecular screen for acute leukemia. Fifteen fusion transcripts were included: BCR-ABL1, PML-RARA, ZBTB16-RARA, RUNX1-RUNX1T1, CBFB-MYH11, DEK-NUP214, TCF3-PBX1, ETV6-RUNX1, MLL-AFF1, MLL-MLLT4, MLL-MLLT3, MLL-MLLT10, MLL-ELL, MLL-MLLT1, and MLL-MLLT6. A total of 121 diagnostic acute leukemia specimens were studied, comparing the mRT-PCR system with standard cytogenetics. Fifty-six cases (46.3%) had fusion transcripts revealed by our mRT-PCR assay. The concordance rate between mRT-PCR and cytogenetics was 91.7%. However, false negative results were found in three cases who have inv(16), t(4;11) or t(11;19)(q23;p13.1), respectively. Seven cryptic translocations including ETV6-RUNX1, MLL-MLLT3, MLL-MLLT4, and PML-RARA were detected. This mRT-PCR assay is a useful screening tool in acute leukemia because it provides rapid and reliable detection of clinically important chimeric transcripts. In addition, cryptic translocations provide additional genetic information that could be clinically useful.
Acute Disease
;
Adolescent
;
Adult
;
Aged
;
Child
;
Child, Preschool
;
Chromosome Inversion
;
Cytogenetics
;
Female
;
Humans
;
Infant
;
Leukemia/*diagnosis/genetics/metabolism
;
Male
;
Middle Aged
;
*Multiplex Polymerase Chain Reaction
;
Oncogene Proteins, Fusion/*genetics
;
Prognosis
;
Translocation, Genetic
;
Young Adult
10.Clinical Importance of Morphological Multilineage Dysplasia in Acute Myeloid Leukemia with Myelodysplasia Related Changes.
Sang Hyuk PARK ; Hyun Sook CHI ; Seo Jin PARK ; Seongsoo JANG ; Chan Jeoung PARK
The Korean Journal of Laboratory Medicine 2010;30(3):231-238
BACKGROUND: AML with myelodysplasia related changes (AML MRC) is known to show a poor prognosis compared with de novo AML, but controversies exist about the prognostic impact of multilineage dysplasia (MLD) among MRC. We investigated the prognostic impact of MLD in AML MRC. METHODS: A total of 357 patients newly diagnosed as AML at Asan Medical Center from January 2001 to December 2005 were analyzed. They were diagnosed and classified as AML with recurrent genetic abnormalities, AML MRC, and AML not otherwise specified (AML NOS). Prognostic markers including overall survival (OS) and event free survival (EFS) were obtained through retrospective analysis of electronic medical records. RESULTS: AML MRC patients showed a lower complete remission (CR) rate (44.7% vs. 64.9%, P=0.002) and shorter OS (297 vs. 561 days, P=0.004) and EFS (229 vs. 374 days, P=0.004) than AML NOS patients. Patients with MLD among AML MRC also showed a lower CR rate (37.7%, P=0.001) and shorter OS (351 days, P=0.036) and EFS (242 days, P=0.076) than AML NOS patients. However, among AML MRC patients, there were no differences in OS, EFS and CR between patients with and without MLD. CONCLUSIONS: AML MRC patients showed a lower CR rate and shorter OS and EFS than AML NOS patients. AML MRC patients with MLD showed similar results and their prognosis was not different from those without MLD. MLD findings among AML MRC could be an independent poor prognostic factor in de novo AML.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Cell Lineage
;
Child
;
Child, Preschool
;
Data Interpretation, Statistical
;
Disease-Free Survival
;
Female
;
Humans
;
Infant
;
Leukemia, Myeloid, Acute/complications/diagnosis/*mortality
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes/complications/*diagnosis
;
Prognosis
;
Retrospective Studies
;
Survival Analysis